AngioDynamics Income Tax Expense vs Cost of Revenue Analysis

ANGO Stock

USD 6.31 0.06 0.94%

AngioDynamics financial indicator trend analysis is way more than just evaluating AngioDynamics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AngioDynamics is a good investment. Please check the relationship between AngioDynamics Income Tax Expense and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

Income Tax Expense vs Cost Of Revenue

Income Tax Expense vs Cost of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AngioDynamics Income Tax Expense account and Cost of Revenue. At this time, the significance of the direction appears to have almost no relationship.

The correlation between AngioDynamics' Income Tax Expense and Cost of Revenue is 0.19. Overlapping area represents the amount of variation of Income Tax Expense that can explain the historical movement of Cost of Revenue in the same time period over historical financial statements of AngioDynamics, assuming nothing else is changed. The correlation between historical values of AngioDynamics' Income Tax Expense and Cost of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Tax Expense of AngioDynamics are associated (or correlated) with its Cost of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost of Revenue has no effect on the direction of Income Tax Expense i.e., AngioDynamics' Income Tax Expense and Cost of Revenue go up and down completely randomly.

Correlation Coefficient

0.19

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Income Tax Expense

Cost Of Revenue

Cost of Revenue is found on AngioDynamics income statement and represents the costs associated with goods and services AngioDynamics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from AngioDynamics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AngioDynamics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.At this time, AngioDynamics' Discontinued Operations is very stable compared to the past year. As of the 16th of April 2024, Enterprise Value is likely to grow to about 352.9 M, while Selling General Administrative is likely to drop about 27.5 M.

	2021	2022	2023	2024 (projected)
Gross Profit	165.7M	174.2M	200.4M	129.6M
Total Revenue	316.2M	338.8M	389.6M	242.9M

Gross Profit Total Revenue

AngioDynamics fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Common Stock Shares Outstanding		0.66	0.1	0.36	0.88	0.7	0.52	0.1	-0.15	-0.31	0.44	0.31	0.58	0.16	0.1	0.27	0.7	0.95	-0.34	0.26	0.78	-0.08	0.96	0.5	0.48	0.63
Total Assets	0.66		0.78	0.09	0.67	0.99	0.73	0.28	0.33	0.39	0.26	0.35	0.97	0.1	0.78	0.36	0.76	0.77	0.16	0.84	0.76	0.36	0.73	0.92	0.48	0.72
Short Long Term Debt Total	0.1	0.78		-0.17	0.27	0.68	0.63	0.18	0.66	0.75	0.03	0.13	0.81	0.01	0.99	0.15	0.56	0.24	0.39	0.95	0.43	0.54	0.19	0.89	0.3	0.4
Other Current Liab	0.36	0.09	-0.17		0.5	0.11	0.1	-0.66	-0.38	-0.59	0.8	0.31	-0.05	0.18	-0.13	0.33	0.32	0.37	-0.15	-0.14	0.12	0.01	0.4	0.04	0.08	0.44
Total Current Liabilities	0.88	0.67	0.27	0.5		0.66	0.65	-0.12	0.02	-0.26	0.61	0.26	0.58	0.17	0.28	0.25	0.87	0.9	-0.08	0.34	0.76	0.17	0.91	0.61	0.59	0.66
Total Stockholder Equity	0.7	0.99	0.68	0.11	0.66		0.66	0.35	0.21	0.32	0.25	0.41	0.94	0.15	0.69	0.42	0.72	0.81	0.14	0.75	0.75	0.31	0.77	0.84	0.46	0.77
Property Plant And Equipment Net	0.52	0.73	0.63	0.1	0.65	0.66		-0.2	0.71	0.13	0.44	-0.3	0.82	0.2	0.63	-0.3	0.88	0.63	0.31	0.71	0.82	0.54	0.61	0.8	0.78	0.2
Current Deferred Revenue	0.1	0.28	0.18	-0.66	-0.12	0.35	-0.2		-0.16	0.53	-0.64	0.43	0.25	-0.14	0.17	0.4	-0.19	0.08	-0.07	0.17	-0.02	-0.22	0.05	0.11	-0.08	0.28
Net Debt	-0.15	0.33	0.66	-0.38	0.02	0.21	0.71	-0.16		0.44	-0.01	-0.65	0.52	-0.01	0.64	-0.64	0.43	-0.02	0.48	0.65	0.4	0.59	-0.06	0.56	0.45	-0.34
Retained Earnings	-0.31	0.39	0.75	-0.59	-0.26	0.32	0.13	0.53	0.44		-0.57	0.19	0.43	-0.2	0.74	0.19	-0.02	-0.23	0.33	0.67	-0.08	0.26	-0.28	0.49	-0.1	0.13
Accounts Payable	0.44	0.26	0.03	0.8	0.61	0.25	0.44	-0.64	-0.01	-0.57		0.01	0.19	0.4	0.07	0.05	0.6	0.5	0.02	0.05	0.46	0.35	0.52	0.24	0.39	0.35
Cash	0.31	0.35	0.13	0.31	0.26	0.41	-0.3	0.43	-0.65	0.19	0.01		0.13	0.0	0.16	1.0	0.0	0.28	-0.24	0.1	-0.1	-0.24	0.28	0.17	-0.3	0.85
Non Current Assets Total	0.58	0.97	0.81	-0.05	0.58	0.94	0.82	0.25	0.52	0.43	0.19	0.13		0.08	0.8	0.13	0.76	0.7	0.22	0.89	0.79	0.4	0.65	0.94	0.55	0.53
Other Assets	0.16	0.1	0.01	0.18	0.17	0.15	0.2	-0.14	-0.01	-0.2	0.4	0.0	0.08		0.06	0.03	0.17	0.22	0.15	-0.07	0.15	0.19	0.22	-0.01	0.07	0.12
Long Term Debt	0.1	0.78	0.99	-0.13	0.28	0.69	0.63	0.17	0.64	0.74	0.07	0.16	0.8	0.06		0.18	0.55	0.26	0.44	0.94	0.43	0.57	0.2	0.89	0.27	0.43
Cash And Short Term Investments	0.27	0.36	0.15	0.33	0.25	0.42	-0.3	0.4	-0.64	0.19	0.05	1.0	0.13	0.03	0.18		0.0	0.27	-0.18	0.11	-0.11	-0.2	0.27	0.17	-0.3	0.85
Net Receivables	0.7	0.76	0.56	0.32	0.87	0.72	0.88	-0.19	0.43	-0.02	0.6	0.0	0.76	0.17	0.55	0.0		0.79	0.14	0.6	0.85	0.51	0.77	0.78	0.75	0.5
Common Stock Total Equity	0.95	0.77	0.24	0.37	0.9	0.81	0.63	0.08	-0.02	-0.23	0.5	0.28	0.7	0.22	0.26	0.27	0.79		-0.04	0.36	0.87	0.15	1.0	0.59	0.55	0.68
Short Term Investments	-0.34	0.16	0.39	-0.15	-0.08	0.14	0.31	-0.07	0.48	0.33	0.02	-0.24	0.22	0.15	0.44	-0.18	0.14	-0.04		0.25	0.12	0.71	-0.06	0.18	0.17	-0.07
Non Current Liabilities Total	0.26	0.84	0.95	-0.14	0.34	0.75	0.71	0.17	0.65	0.67	0.05	0.1	0.89	-0.07	0.94	0.11	0.6	0.36	0.25		0.55	0.42	0.31	0.96	0.35	0.41
Inventory	0.78	0.76	0.43	0.12	0.76	0.75	0.82	-0.02	0.4	-0.08	0.46	-0.1	0.79	0.15	0.43	-0.11	0.85	0.87	0.12	0.55		0.43	0.85	0.7	0.63	0.41
Other Current Assets	-0.08	0.36	0.54	0.01	0.17	0.31	0.54	-0.22	0.59	0.26	0.35	-0.24	0.4	0.19	0.57	-0.2	0.51	0.15	0.71	0.42	0.43		0.13	0.41	0.32	0.09
Other Stockholder Equity	0.96	0.73	0.19	0.4	0.91	0.77	0.61	0.05	-0.06	-0.28	0.52	0.28	0.65	0.22	0.2	0.27	0.77	1.0	-0.06	0.31	0.85	0.13		0.55	0.55	0.68
Total Liab	0.5	0.92	0.89	0.04	0.61	0.84	0.8	0.11	0.56	0.49	0.24	0.17	0.94	-0.01	0.89	0.17	0.78	0.59	0.18	0.96	0.7	0.41	0.55		0.48	0.55
Property Plant And Equipment Gross	0.48	0.48	0.3	0.08	0.59	0.46	0.78	-0.08	0.45	-0.1	0.39	-0.3	0.55	0.07	0.27	-0.3	0.75	0.55	0.17	0.35	0.63	0.32	0.55	0.48		0.12
Total Current Assets	0.63	0.72	0.4	0.44	0.66	0.77	0.2	0.28	-0.34	0.13	0.35	0.85	0.53	0.12	0.43	0.85	0.5	0.68	-0.07	0.41	0.41	0.09	0.68	0.55	0.12

Click cells to compare fundamentals

AngioDynamics Account Relationship Matchups

AngioDynamics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	38.0M	38.3M	39.0M	39.5M	45.4M	29.4M
Total Assets	595.5M	561.4M	552.8M	532.6M	612.5M	533.4M
Short Long Term Debt Total	40.8M	20M	33.8M	49.8M	57.3M	66.3M
Other Current Liab	2.1M	38.0M	21.5M	43.4M	49.9M	52.4M
Total Current Liabilities	51.5M	57.6M	74.3M	83.8M	96.4M	48.7M
Total Stockholder Equity	455.9M	439.5M	424.5M	378.3M	435.0M	404.2M
Property Plant And Equipment Net	28.3M	37.1M	45.0M	44.4M	51.0M	35.0M
Net Debt	(13.6M)	(28.2M)	5.0M	5.2M	6.0M	5.7M
Retained Earnings	(100.3M)	(131.9M)	(158.4M)	(210.9M)	(189.8M)	(180.3M)
Accounts Payable	19.1M	19.6M	28.0M	40.4M	46.5M	48.8M
Cash	54.4M	48.2M	28.8M	44.6M	51.3M	45.7M
Non Current Assets Total	442.6M	420.6M	409.4M	369.1M	424.5M	382.2M
Other Assets	5.2M	3.8M	11.0M	49.2M	56.6M	59.4M
Long Term Debt	40M	20M	25M	49.8M	57.3M	58.7M
Cash And Short Term Investments	54.4M	48.2M	28.8M	44.6M	51.3M	61.7M
Net Receivables	31.3M	35.4M	52.3M	52.8M	60.7M	38.3M
Common Stock Total Equity	374K	377K	380K	382K	439.3K	308.9K
Liabilities And Stockholders Equity	595.5M	561.4M	552.8M	532.6M	612.5M	533.4M
Non Current Liabilities Total	88.1M	64.4M	53.9M	70.5M	81.1M	80.5M
Inventory	59.9M	48.6M	51.4M	55.3M	63.6M	42.5M
Other Current Assets	2.2M	1.8M	2.2M	4.6M	4.2M	4.5M
Other Stockholder Equity	557.2M	567.8M	581.2M	593.5M	682.5M	424.4M
Total Liab	139.6M	122.0M	128.3M	154.3M	177.5M	129.1M
Property Plant And Equipment Gross	28.3M	37.1M	96.1M	44.4M	51.0M	37.5M
Total Current Assets	152.9M	140.9M	143.3M	163.5M	188.1M	151.2M
Accumulated Other Comprehensive Income	(1.3M)	3.2M	1.4M	(4.7M)	(5.4M)	(5.2M)
Short Term Debt	836K	2.4M	8.8M	14.8M	17.0M	8.5M
Intangible Assets	197.1M	169.0M	152.4M	111.1M	127.8M	113.3M
Common Stock	374K	377K	380K	382K	439.3K	309.7K
Property Plant Equipment	28.3M	37.1M	45.0M	44.4M	51.0M	34.9M
Non Currrent Assets Other	15.6M	13.2M	(5.1M)	54.3M	62.5M	65.6M
Other Liab	39.6M	37.1M	24.2M	17.4M	20.0M	32.6M
Good Will	201.5M	201.3M	201.1M	159.2M	183.1M	283.9M
Net Tangible Assets	57.2M	69.2M	71.1M	378.3M	435.0M	456.8M
Retained Earnings Total Equity	(100.3M)	(131.9M)	(158.4M)	(210.9M)	(189.8M)	(180.3M)
Long Term Debt Total	40M	20M	25M	49.8M	44.8M	69.2M
Capital Surpluse	561.9M	573.5M	586.9M	599.2M	689.1M	600.4M
Deferred Long Term Liab	24.1M	20.0M	16.0M	12.8M	14.7M	14.1M

Pair Trading with AngioDynamics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.

Moving against AngioDynamics Stock

0.65	NXGL	Nexgel Inc	Pair Corr
0.49	ENSG	Ensign Group Financial Report 24th of April 2024	Pair Corr
0.47	COO	Cooper Companies Financial Report 6th of June 2024	Pair Corr
0.47	CVS	CVS Health Corp Financial Report 1st of May 2024	Pair Corr
0.44	POAI	Predictive Oncology	Pair Corr

The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.

The correlation of AngioDynamics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:

How To Invest In AngioDynamics

Details

Is AngioDynamics Stock a good investment?

Details

What is AngioDynamics' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics' price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.

	Transaction History View history of all your transactions and understand their impact on performance
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing

Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.80)

Revenue Per Share

8.105

Quarterly Revenue Growth

(0.07)

Return On Assets

(0.05)

Return On Equity

(0.62)

The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

AngioDynamics Income Tax Expense vs Cost of Revenue Analysis

Income Tax Expense vs Cost Of Revenue

Income Tax Expense vs Cost of Revenue Correlation Analysis

Correlation Coefficient

Income Tax Expense

Cost Of Revenue

AngioDynamics fundamental ratios Correlations

AngioDynamics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

AngioDynamics fundamental ratios Accounts

Pair Trading with AngioDynamics

Moving against AngioDynamics Stock

Complementary Tools for AngioDynamics Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Other Stockholder Equity	+ 1.0	Common Stock Total Equity
Total Stockholder Equity	+ 0.99	Total Assets
Long Term Debt	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.97	Total Assets
Other Stockholder Equity	+ 0.96	Common Stock Shares Outstanding

Current Deferred Revenue	- 0.66	Other Current Liab
Cash	- 0.65	Net Debt
Cash And Short Term Investments	- 0.64	Net Debt
Accounts Payable	- 0.64	Current Deferred Revenue
Retained Earnings	- 0.59	Other Current Liab
Accounts Payable	- 0.57	Retained Earnings